Results 91 to 100 of about 6,680,139 (200)

Author Correction: Production of an immunogenic trivalent poliovirus virus-like particle vaccine candidate in yeast using controlled fermentation. [PDF]

NPJ Vaccines
Sherry L, Grehan K, Bahar MW, Swanson JJ, Fox H, Matthews S, Carlyle S, Qin L, Porta C, Wilkinson S, Robb S, Clark N, Liddell J, Fry EE, Stuart DI, Macadam AJ, Rowlands DJ, Stonehouse NJ.   +17 more
europepmc   +1 more source

Foot-and-mouth disease virus-like particle mRNA vaccine induces strong humoral and cellular immunity. [PDF]

Appl Microbiol Biotechnol
Liu H, Zhang Y, Mu S, Hou F, Jiang L, Wang Z, Dong H, Mehdi MM, Guo H, Sun S.   +9 more
europepmc   +1 more source

Virus-like Particle [PDF]

, 2020
openaire   +1 more source

Development of a 12-Valent HPV L1 Virus-like Particle Vaccine Using an Enhanced Baculovirus Expression System. [PDF]

Vaccines (Basel)
Kim JD, Kim EH, Lee JH, Kim SY, Oh JM, Cho Y, Kim H, Gwak W, Woo SD, Han BK, Choi JB.   +10 more
europepmc   +1 more source

Genome-wide screening reveals producer-cell modifications that improve virus-like particle production and delivery potency. [PDF]

Nat Commun
Ly D, Jang H, Goel A, Singh A, Raguram A.   +4 more
europepmc   +1 more source

Coxsackie B1 virus-like particle that lacks VP4 protein demonstrates improved vaccine scalability, stability and immunogenicity. [PDF]

J Biomed Sci
Soppela S, Kyröläinen HM, Levanova A, Nekoua MP, González-Rodríguez M, Lehto H, Ahmad KLL, Guryanov S, Hytönen VP, Laitinen OH, Junttila IS, Hober D, Butcher SJ, Hankaniemi MM.   +13 more
europepmc   +1 more source

Protocol for enhancing CRISPR-Cas9 genome editing using histone deacetylase inhibition and engineered virus-like particle delivery. [PDF]

STAR Protoc
Djamshidi M, Tanida R, Heshmatzad K, Krowicki H, Hill A, Yang Y, Riabowol K.   +6 more
europepmc   +1 more source

How much genetic information in RNA form can be protected by a CCMV virus-like particle? [PDF]

PLoS One
Duran Meza AL, Porak SC, Chapman A, Knobler CM, Gelbart WM.   +4 more
europepmc   +1 more source

Evaluation of cellular immune response and biosafety of SV40 virus-like particle in tumor immunotherapy. [PDF]

J Mater Sci Mater Med
He T, Hei R, Liu C, Wang H, Gao Z, Dong K, Zhang J.   +6 more
europepmc   +1 more source

Multiscale Simulations and Cryo-Electron Microscopy Reveal the Transition Pathway of Dengue Virus-like Particle Nanoassembly. [PDF]

ACS Nano
Palur VR, Chen GW, Chao DY, Kuo WS, Wu YN, Galula JU, Wang CH, Chen FC, Bond PJ, Marzinek JK, Wu SR.   +10 more
europepmc   +1 more source